Outcome of primary angioplasty for acute myocardial infarction during routine duty hours versus during off-hours

Journal of the American College of Cardiology

Volumn 41, Issue 12, 2003, Pages 2138-2142

  Henriques, Jose P S ^a   Haasdijk, Arnout P ^a   Zijlstra, Felix ^a  

^a HOSPITAL DE WEEZENLANDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; ARTICLE; CIRCADIAN RHYTHM; FEMALE; HEALTH CARE QUALITY; HEART MUSCLE REPERFUSION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; ST SEGMENT ELEVATION; SYMPTOMATOLOGY; WORK SCHEDULE;

EID: 0038037765     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00461-3     Document Type: Article

References (28)

1. Muller JE, Stone PH, Turi ZG, et al., and the MILIS Study Group. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313:1315-22.
2. ISIS-2 Collaborative Group. Morning peak in the incidence of myocardial infarction: experience in the ISIS-2 trial. Eur Heart J 1992;13:594-8.
3. Willich SN, Klatt S, Arntz HR. Circadian variation and triggers of acute coronary syndromes. Eur Heart J 1998;19:C12-23.
4. Arntz HR, Willich SN, Schreiber C, et al. Diurnal, weekly and seasonal variation of sudden death. Population-based analysis of 24,061 consecutive cases. Eur Heart J 2000;21:315-20.
5. Cannon CP, McCabe CH, Stone PH, et al., for the TIMI III Registry and TIMI IIIB Investigators. Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB). Am J Cardiol 1997;79:253-8.
6. Muller JE. Circadian variation and triggering of acute coronary events. Am Heart J 1999;137:S1-8.
7. Zahn R, Schiele R, Seidl K, et al. Daytime and nighttime differences in patterns of performance of primary angioplasty in the treatment of patients with acute myocardial infarction. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Am Heart J 1999;138:1111-7.
8. Zijlstra F, Ernst N, de Boer MJ, et al. Influence of pre hospital administration of aspirin and heparin on initial patency of the infarct related artery in patients with acute ST elevation myocardial infarction. J Am Coll Cardiol 2002;39:1733-7.
9. Mukamal KJ, Muller JE, Maclure M, et al. Increased risk of congestive heart failure among infarctions with nighttime onset. Am Heart J 2000;140:438-42.
10. Petralito A, Mangiafico RA, Gibiino S, et al. Daily modifications of plasma fibrinogen, platelet aggregation, Howell's time, PTT, TT, and antithrombin III in normal subjects and in patients with vascular diseases. Chronobiologia 1982;9:195-201.
11. Tofler GH, Brezinski DA, Schafer AI, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987;316:1514-8.
12. Fujita M, Franklin D. Diurnal changes in coronary blood flow in conscious dogs. Circulation 1987;76:488-91.
13. Ehrly AM, Jung G. Circadian rhythm of human blood viscosity. Biorheology 1973;10:577-83.
14. Weitzman ED, Fukushima D, Nogeire C, et al. Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. J Clin Endocrinol Metab 1971;33:14-22.
15. Turton MB, Deegan T. Circadian variations of plasma catecholamine, cortisol, and immunoreactive insulin concentrations in supine subjects. Clin Chim Acta 1974;55:389-97.
16. Decousus H, Croze M, Levi FA, et al. Circadian changes in anticoagulant effect of heparin infused at a constant rate. Br Med J 1985;290:341-4.
17. Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989;79:101-6.
18. Andreotti F, Davies GJ, Hackett DR, et al. Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am J Cardiol 1988;62:635-7.
19. Grimaudo V, Hauert J, Bachmann F, et al. Diurnal variation of the fibrinolytic system. Thromb Haemost 1988;59:495-9.
20. Rosing DR, Redwood DR, Brakman P, et al. Impairment of the diurnal fibrinolytic response in man. Circ Res 1973;32:752-8.
21. Kurnik PB. Circadian variation in the efficacy of tissue-type plasminogen activator. Circulation 1995;91:1341-6.
22. Kono T, Morita H, Nishina T, et al. Circadian variations of onset of acute myocardial infarction and efficacy of thrombotic therapy. J Am Coll Cardiol 1996;27:774-8.
23. Goldhammer E, Kharash L, Abinader EG. Circadian fluctuations in the efficacy of thrombolysis with streptokinase. Postgrad Med J 1999;75:667-71.
24. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283:2941-7.
25. Magid DJ, Calonge BN, Rumsfeld JS, et al. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs. thrombolytic therapy. JAMA 2000;284:3131-8.
26. Canto JG, Every NR, Magid DJ, et al., for the National Registry of Myocardial Infarction 2 Investigators. The volume of primary angioplasty procedures and survival after myocardial infarction. N Engl J Med 2000;342:1573-80.
27. Vakili BA, Kaplan R, Brown DL. Volume-outcome relation for physicians and hospitals performing angioplasty for acute myocardial infarction in New York State. Circulation 2001;104:2171-6.
28. Christian TF, O'Keefe JH, DeWood MA, et al. Intercenter variability in outcome for patients treated with direct coronary angioplasty during acute myocardial infarction. Am Heart J 1998;135:310-7.